Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.

Immune signaling in IBD triggers tumor-promoting neutrophils which is linked to an increased risk of colorectal cancer.

When the team knocked out the P2Y2 receptor in drug-resistant cancer cells, it led to an almost complete loss of the mutant EGFR protein.

MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

Ongoing combination of Twist NGS library preparation kits with firefly will continue to expand SPT Labtech’s portfolio of ...

The discovery fundamentally changes the understanding of a structure in the avian eye that has been misinterpreted for centuries.

The new investment in the Holly Springs facility is on top of the initial commitment in May 2025, and groundbreaking in August 2025.

D printing is a good option for bioreactor production. The flexibility of the approach outweighs concerns about higher costs.

The so-called magneto-sensitive fluorescent proteins or MFPs, overcome key limitations of previous biological candidates for quantum sensors.

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...